HRES803-119

In Committee

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

119th Congress Introduced Oct 10, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abo

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.

At a Glance

What This Bill Does

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abo

Key Policy Areas

Government

Primary Purpose

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abo

Policy Domains

Government

Legislative Strategy

"Policy"

Legislative Progress

In Committee
Introduced Committee Passed
Oct 10, 2025

Mr. Rose (for himself, Mrs. Harshbarger, Mr. Carter of Georgia, …

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology